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Abstract: Depletion of intracellular calcium stores by ag-
onist stimulation is coupled to calcium influx across the
plasma membrane, a process termed capacitative cal-
cium entry. Capacitative calcium entry was examined in
cultured guinea pig enteric glial cells exposed to endo-
thelin 3. Endothelin 3 (10 nM) caused mobilization of
intracellular calcium stores followed by influx of extracel-
lular calcium. This capacitative calcium influx was inhib-
ited by Ni2~(89 ±2%) and by La3~(78 ±2%) but wasnot affected by L-, N-, or P-type calcium channel block-
ers. Chelerythrine, a specific antagonist of protein kinase
C, dose-dependently inhibited capacitative calcium entry.
The nitric oxidesynthase inhibitor N°-nitro~L-argininede-
creased calcium influx in a dose-dependent manner. The
combination of chelerythrine and NG~nitro~L_argininepro-
duced synergistic inhibitory effects. Capacitative calcium
entry occurs in enteric glial cellsvia lanthanum-inhibitable
channels through a process regulated by protein kinase
C and nitric oxide. Key Words: Glial cell—Calcium—
Endothelin—Myenteric plexus.
J. Neurochem. 71, 205—212 (1998).
Initially identified as potent constrictors of vascular
smooth muscle, endothelins (ETs) have been demon-
strated to have a broader array of biological effects,
ranging from smooth muscle contraction, to cell
growth, to neuronal signal transduction (Stojilkovic
and Catt, 1992; Battistini et al., 1993; Huggins et al.,
1993; Stephenson et a!., 1994). In the gastrointestinal
system, ETs havebeen reported to influence acetylcho-
line-induced intestinal contractility, contraction of iso-
lated smooth muscle cells (Yoshinaga et al., 1992),
colonic secretion (Kiyohara et al., 1993), and develop-
ment of the enteric nervous system (Baynash et al.,
1994). Disruptionof the endothelin B (ET-B) receptor
gene in mice results in aganglionic megacolon resem-
bling human Hirschsprung’ s disease (Puffenberger et
a!., 1994). These observations suggest potential roles
for ETs in regulation of gastrointestinal function, al-
though involved mechanisms remain undefined.
The enteric nervous system is composed of a mix-
ture of cell types, including neurons, glial cells, and
occasional fibroblasts. Glia outnumber neurons and are
usually depicted as having supportive or nutritive roles
for enteric neurons. Recent studies suggest that enteric
glia may also function in information transfer. Enteric
glia have cell-to-cell coupling and respond to a variety
of neuroligands, including ETs, with calcium signaling
(Kimball and Mulholland, 1996; Zhang et al., 1997).
Enteric glia possess an ET-B receptor linked to phos-
pholipase C.
In several cell types, the actions of ETs are associ-
ated with increases in intracellular calcium concentra-
tion ([Ca 2± ~). Recent studies have demonstrated that
ET-evoked increments in [Ca2~I, are composed of an
initial rapid, but transient, response caused by release
of intracellular calcium stores and a subsequent pro-
longed elevation mediated via extracellular calcium
entry (Supattapone et al., 1989; Highsmith et al., 1992;
Stojilkovic and Catt, 1992). There is strong evidence
that inositol trisphosphate-sensitive intracellular stores
are responsible for the initial response (Highsmith et
al., 1992; Stojilkovic et al., 1992; Zhang et al., 1997).
The mechanisms controlling the prolonged elevation
of [Ca2~ I, have not been determined. In nonexcitable
cells, calcium released from intracellular stores induces
calcium influx across the plasma membrane, a process
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termed capacitative calcium entry (Putney, 1990; Put-
ney and Bird, 1993; Berridge, 1995). Capacitative cal-
cium entry can be observed in several cell types after
experimental measures that deplete calcium from intra-
cellular stores (Putney, 1991). In the present study,
depletion of intracellular calcium stores by ET caused
capacitative calcium entry in enteric glia. The current
studies indicate that (1) ET evokes calcium influx in
cultured enteric glia via activation of non-L-, non-N-,
or non-P-type calcium channels; (2) capacitative cal-
cium influx is regulated by protein kinase C (PKC)
and nitric oxide (NO) synthase (NOS); and (3) PKC




Endothelin 3 (ET3) was purchased from Peninsula La-
boratories (Belmont, CA, U.S.A.). NG~Nitro~L~arginine
(L-NA), N°-nitro-D-arginine (D-NA), NG~monomethyl~L~
arginine monoacetate (L-NMMA), L-N
5- (I -i inoethyl) or-
nithine (L-NIO), S-methyl-L-thiocitrulline (Me-TC), (±)-
(E)-ethyl- 2- [(E) -hydroxyimino] -5 -nitro- 3 -hexeneamide
(NOR3), (±)- S-nitroso- N-acetylpenicillamine (SNAP),
and sodium nitroprusside (SNP) were from Calbiochem
(San Diego, CA, U.S.A.). Fura-2 acetoxymethyl ester (fura-
2/AM) and fura-2-free acid were from Molecular Probes
(Eugene, OR, U.S.A.). Nickel chloride, lanthanum chloride,
collagenasetype V, trypsin-EDTA, trypsin inhibitor, penicil-
lin—streptomycin solution, and HEPES were from Sigma
Chemical (St. Louis, MO, U.S.A.). Phorbol 12-myristate 13-
acetate (PMA), chelerythrine, conotoxin GIVA, agatoxin,
and diltiazem were obtained from Research Biochemicals
International (Natick, MA, U.S.A.). 4ct-Phorbol 12-myris-
tate 13-acetate (4a-PMA) was purchased from LC Labora-
tories (Woburn, MA, U.S.A.). Hanks’ balanced salt solution,
medium 199, and L-glutamic acid were from GibcoBRL
(Grand Island, NY, U.S.A.). Neonatal male Duncan—
Hartley guinea pigs were obtained from Simonsen Labora-
tories (Gilroy, CA, U.S.A.).
Solutions
All experiments were performed in standardized solutions
except when noted. Standard control buffer was a modified
Krebs—Ringer solution at pH 7.40, containing (in mM):
NaC1 118, KC1 4.7, CaC1
2 1.8, HEPES 10, NaHCO3 15,
glucose 11, NaH2PO4 0.9, and MgSO4 0.8. For calcium-free
control buffer, CaC12 was removed and 1 mM EGTA was
added. In experiments where Ba
2~ions are used, HC0
3,
S2O42_, and H2P04 were removed from all solutions, as
they form insoluble salts with Ba
2~.
Myenteric plexus isolation
Dispersed primary cultures of guinea pig myenteric plexus
were prepared on collagen-coated coverslips and used for
experiments within 5 days. Taeniae coli from 1-day-oldmale
Duncan—Hartley guinea pigs were removed and placed in
Hanks’ balancedsalt solution plus 0.1% collagenase for 16—
20 h at 4°C.After a 35-mm incubation at 37°C,the muscle
layers of the taeniae coli were separated from the myenteric
plexus by using a dissecting microscope. The plexus was
trypsinizedfor 30 mm at 37°C,using trypsin-EDTA solution,
triturated with siliconized flamedPasteur pipettes of decreas-
ing tip diameter, and plated on collagen-coated coverslips.
Cultures were exposed to complete medium 199 plus 5% NU
serum and0.001% trypsin inhibitor (type I-S from soybean).
Penicillin—streptomycin solution was added for the first 48
h at a 2% concentration. Antimitotic agents were not added.
Media were changed every other day. The cultures were
incubated at 37°Cwith 5% CO
2.
Cell preparation for imaging
Cultured plexus was incubated at 37°Cin fresh warmed
media containing 2—3 ~sMfura-2/AM for 45 mm. Loaded
coverslips were washed, resuspended in standard control
buffer, and placed in a Lucite superfusion chamber. The
superfusion rate of the control buffer and experimental solu-
tions was 1 ml/min at 37°C.
Calcium measurements
A Zeiss Axiovert inverted microscope and Attofluor digi-
tal imaging system (Rockville, MD, U.S.A.) were used for
single-cell [Ca
2~], determinations. [Ca2~], was calculated
from th ratios of the fluorescence intensities of fura-2 at
334- and 380-nm wavelengths with an emission wavelength
of 500 nm. Calibration of thesystem wasperformed by using
fura-2-free acid with the two-point standardization equation:
[Ca2~]~ = K
0{[R — R(Lo)]/[R(Hi) — R]}b, where K~
= dissociation constant of the Ca
2~/fura-2complex (225
nM), R = F
534/F350, i.e., the fluorescence at 334-nm excita-
tion divided by the fluorescence at 380-nm excitation, R (Lo)
= ratio at zero calcium (1 mM EGTA), R(Hi) = ratio at




2~).Frames were not averaged. A ratio pair
w s take every second.
In some experiments, Ba2~ions were substituted for Ca2~
ions to measure rates of ion entry into glia cells. Ba2~ions
cause fura-2 to produce fluorescence ratio changes in a fash-
ion similar to Ca2~ions. However, unlike Ca2~ions, Ba2~
cannot be sequestered in internal stores and, therefore, pro-
vides an isolated measure of divalent cation entry in cells
(Kwan and Putney, 1990). In the Ba2~experiments, the




Capacitative calcium entry was experimentally defined as
the rise in [Ca
2~ 1, that occurred after the return of calcium
o the xtracellular buffer after depletion of internal stores
in calcium-free buffer. This was assessed by measuring the
change in [Ca2~ I, before reintroduction of calcium relative
to the peak value observed with the return of calcium. In
inhibitory experiments, capacitative calcium entry was nor-
malized to the control in which no inhibitor was added and
was expressed as a percentage of control.
Results are presented as mean ±SEM values. Data were
analyzed by using unpaired Student’s t test. Significance was
accepted as p < 0.05.
Dissection techniques, tissue preparation, media, and re-
agent vendors remained constant throughout the study. In
this study, n = number of glial cells. At least threecoverslips
were used for each experimental condition. All experimental
conditions were examined on glial cells derived from cell
preparations performed on at least 2 different days.
Results have been calculated only from those responding
glia having basal [Ca2~I~ levels of <150 nM, a criterion
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FIG. 1. El caused capacitative calcium entry in enteric glia. A:
In Ca2~-containing buffer, ET3 (10 nM) caused an initial (Cas*i
response followed by sustained elevation of (Ca
2~]~.B: Applica-
tion f ET
3 (10 nM) in Ca
2~-fre buffer induced the release of
calcium from intracellular stores and activation of calcium influx
as indicated by the sustained increase of [Ca2~J,after addition
of 1.8 mM calcium to the superfusion medium (n = 325).
met by >95% of glial cells. Those glia with a high [Ca2~]
1
before addition of agonist were considered damaged or leaky
and were excluded from the study. There was only one mi-
croscope field examined per coverslip. Peak [Ca
2~]~was
measured as the highest Ca2~conc ntration chieved during
agonist exposure.
At the time of the experiments, the following two criteria
were used to determine whether cells of interest were glia
as opposed to neurons: (1) morphology: myenteric neurons
2—7 days after plating are compact, phase bright, with few
or no processes. Enteric glia have a larger, dense nucleus
with wide surrounding cytoplasm; and (2) KC1 depolariza-
tion: at the end of each experiment, the coverslip was super-
fused with 55 mM KC1. This exposure depolarizes neurons
but not glia, increasing their [Ca 2+j
RESULTS
ET-induced capacitative calcium entry
in enteric glia
ET
3 (10 nM) caused a biphasic response in [Ca
2~I,
that was composed of an initial apid but transient
increase and a subsequent prolonged elevation in
[Ca2~I~(Fig. 1A). To observe capacitative calcium
entry in entenc glia, cells were exposed to 10 nM ET
3
in calcium-free buffer for 60 s, followed by calcium-
free buffer for 200 s, and then were superfused with
1.8 mM calcium. Under these conditions, ET3 caused
a transient increase in [Ca
2~I, in calcium-free buff r;
secondary increases in [Ca2~]~ were noted when 1.8
mM calcium was added to the perfusion medium (Fig.
1B). In 12 separate experiments (n = 325), the
[Ca2~]
1increment noted on restitution of buffer Ca
2~
was 176 ±19 nM.
To determine if ET
3-induced capacitative calcium
transients involve calcium entry from extracellular
sources, barium was substituted for calcium in some
experiments. As shown in Fig. 2, barium entered cells
after depletion of calcium from the internal stores by
ET3, indicating that the source of calcium transients
was via influx of extracellular calcium.
Calcium entry involves non-h., non-N-,
or non-P-type calcium channels
To characterize calcium channel types involved in
ET3-evoked capacitative calcium entry in enteric glia,
a panel of calcium channel inhibitors was used. Ni
2~
and La3~are inorganic, nonspecific inhibitors of cal-
cium channels and have been demonstrated to block
capacitative calcium entry in other cell types (Ber-
ridge, 1995). The dihydropyridine compound diltia-
zem is an inhibitor of L-type voltage-gated Ca2~chan-
nels; w-conotoxin and agatoxin are specific inhibitors
for N-type and P-type calcium channels, respectively
(Tsien and Tsien, 1990; Olivera et al., 1994). In all
the inhibition experiments, enteric glia were exposed
to 10 nM ET
3 to mobilize internal calcium stores, fol-
lowed by superfusion with calcium-free buffer plus
inhibitor for 200 s, then buffer containing 1.8 mM
Ca
2~with the same concentration f inhibitor.
As illustrated in Fig. 3, 1 mM Ni2~inhibited ET
3-
evoked capacitative calcium entry by 89 ±2% (n
= 68). The inhibitory effects of Ni2± were reversible.
In a similar manner, 1 mM La
3~produced 78 ±2% (n
= 57) inhibitio of ET
3-stimulated capacitative cal-
cium entry. In contrast, diltiazem, w-conotoxin, and
FIG. 2. Exposure of enteric glia to ET3 (10 nM) in Ca
2~-free
buffer caused a transient incre se of fura-2 fluorescence ratio
(F
334/F350 nm). When 10 mM Ba
2~was added to the Ca2~-free
buffer, the fluoresc ce ratio increased progressively, reflecting
Ba2~influx via the plasma membrane.
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FIG. 3. Reversible inhibition by Ni2~and La3~of ET
3-stimulated capacita-
tive calcium entry in enteric glia. A:
Depletion of intracellular calcium
stores caused a typical capacitative
calcium entry on addition of Ca
2~to th
perfusion buffer. B: Superfusion with 1
mM Ni2~inhibited the increase of
[Ca2~]~when Ca2~was added to the
perfusion buffer. [Ca2~l, increased
when Ni2~was removed. C: Similar to
Ni2~,La3~reversibly inhibited capaci-
tative calcium entry. D: Summary of in-
hibitory effect of Ni2~and La3~.n =
64, 68, and 57, for control, Ni2~,and
La3~,respectively. °p< 0.05, for Ni2~
or La3~vs. control.
agatoxin had no effect on ET
3-induced capacitative
calcium entry (Table 1).
Role of PKC
In some studies, PKC has been suggested to regulate
capacitative calcium entry (Bode and Goke, 1994; Pe-
terson and Berridge, 1994, 1995; Berridge, 1995; Xu
and Ware, 1995; Ribeiro and Putney, 1996). To study
the effect of PKC on ET3-stimulated capacitative cal-
cium entry in enteric glia, cells were pretreated with
100 nM PMA for 16 h to deplete PKC activity before
being used for experiments. As shown in Fig. 4, pre-
treatment of cells with PMA produced a 67 ± 7%
inhibitionof ET3-stimulated capacitative calcium entry
(n = 38). In parallel studies, 100 nM 4a-PMA, an
inactive analogue of PMA, demonstrated no effect (n
= 59). In contrast, short-term pretreatment of glia with
100 nM PMA for 4 mm to activate PKC activity pro-
duced a 6 ±4% increase of ET3-stimulated capacita-
tive calcium entry (p > 0.05).
The effect of PKC on ET3-stimulated capacitative
calcium entry was further studied by using inhibitors
of PKC. Staurosporine, a relatively nonspecific PKC
antagonist, inhibited capacitative calcium entry by 55
± 2% (n = 60) (Fig. 4). Chelerythrine is a newly
described and more specific inhibitor of PKC (Her-
bert et al., 1990). Beginning 60 s before exposure to
10 nM ET3, chelerythrine dose-dependently inhibited
capacitative calcium entry. Chelerythrine at 1 and 5
1uM inhibited capacitative calcium entry by 32 ± 4%
(n = 51) and 54 ± 2% (n = 58), respectively (Fig.
5A). As the effects of chelerythrine could be ex-
plained either by the inhibition of calcium influxfrom
the extracellular sources or by effects on intracellular
stores, barium was substituted for calcium in the su-
perfusion solution. Figure SB illustrates the effects of
1 ~tMchelerythrine on barium entry into enteric glia
after mobilization of internal calcium stores with 10
nM ET3. Relative to controls, glia treated with chel-
erythrine demonstrated smaller increments in fura-2
TABLE 1. Effect of calcium channeI blockers on ET-stimula ted capacitative calcium entry
Control Diltiazem (5 ~tM) Diltiazem (50 ~i!i4) w-Conotoxin (1 1il~4) Agatoxin (10 nM)
% of control 100 ±6 102 ±4 92 ±4 108 ±4 96 ±5
n 57 89 59 86 44
In all inhibition experiments, a single dose of inhibitor was applied 200 s before 1.8 mM Ca
2~,and the same amount of inhibitor was added
to the superfusi buffer. No significant difference (p > 0.05) in capacitative calcium entry was noted between the control and glia treated
with diltiazem, conotoxin, or agatoxin.
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FIG. 4. Effect of PMA and staurosporine on capacitative calcium
entry. Enteric glia were pretreated with 100 nM PMA for 16 h
before exposure to ET3 (n = 38). Pretreatment of glia with 100
nM staurosporine for 30 mm attenuated capacitative calcium
entry (n = 60). Pretreatment of glia with 100 nM 4a-PMA dem-
onstrated no effect (n = 59). *p < 0.01, vs. control.
FIG. 5. A: Chelerythrine dose-dependently inhibited capacita-
tive calcium entry induced by ET3 (10 nM) in enteric glia. Begin-
ning 60 s before exposure to 10 nM ET3, a single dose of chel-
erythrine was used throughout each experiment. n = 43, 62, 51,
and 58, for control, and 0.1, 1, and 5 ~.eMchelerythrine, respec-
tively. °p< 0.01, vs. control. B: The average of 20 tracings.
Chelerythrine (1 jsM) inhibited the Ba
2~influx. Chelerythrine was
appli d to c lls, begin ing 60s before exposure to 10 nM ET
3.
FIG. 6. Effect of NOS inhibitors on the capacitative calcium entry
evoked by E~3in enteric glia. Cultured glia were pretreated with
a single dose of NOS inhibitor for 5 mm and then superfused
with the inhibitor. All NOS inhibitors (1 mM L-NA, 100 ~iML-
NMMA, 100 j.sM L-NlO, and 100 ~iMMe-IC) significantly attenu-
ated capacitative calcium entry caused by El3. 0-NA (1 mM),
used as a negative control for L-NA, demonstrated no effect. In
rescue experiments, 50 p~MSNP was superfused after enteric
glia were exposed to 10 nM ET3. The inhibition caused by 1
mM L-NA was reversed in the presence of 50 1iM SNP. *p
< 0.01.
fluorescent intensity, suggesting that chelerythrine
acts to inhibit calcium entry via the plasma mem-
brane.
Role of nitric oxide (NO)
Several studies have suggested that NO is involved
in the regulation of capacitative calcium entry (Pandol
and Schoeffield-Payne, 1990; Bischof et al., 1995).
Enteric glia were pretreated with a series of inhibitors
of NO synthase for 5 mm and then superfused with
the control buffer in the presence of inhibitor through-
out the experiment. As illustrated in Fig. 6, pretreat-
ment of glia with 1 mM L-NA attenuated capacitative
calcium entry by 35 ± 3% (n = 59). Similar inhibition
was found in experiments using L-NMMA (100 ,aM,
n = 89), L-NIO (100 ~.tM, n = 65), and Me-TC (100
jiM, n = 82). In parallel experiments, D-NA (1 mM),
a negative control for L-NA, demonstrated no inhibi-
tory effect (n = 54). In rescue experiments, simultane-
ous treatment of glia with 10 ,.tM SNP, an NO donor,
restored L-NA-attenuated capacitative calcium entry
(Fig. 6). The inhibitory effect of L-NA was dose de-
pendent (Fig. 7A). None of the NO donors alone, i.e.,
SNP, NOR3, or SNAP, showed an effect on [Ca
2~],
in either resting or stimulated cells (data n t shown).
When barium was substituted for calcium in the
control experiments, rapid increases in intracellular
fluorescent intensity was observed during capacitative
calcium entry (Fig. 7B). In enteric glia pretreatedwith
1 mM L-NA, the rate of increment in intracellular fluo-
rescent intensity was significantly attenuated, indicat-
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FIG. 7. A: The inhibition by L-NA of capacitative calcium entry
elicited by El3 was dose dependent. °p< 0.01. B: Ba
2 influx
was attenuated by the L-NA(1 mM), as indicated by the slower
and smaller increments offluorescence ratio. Shown is the aver-
age of 23 tracings.
ing an effect of L-NA on calcium entry across the
plasma membrane.
Che!erythrine and L-NA act synergistically
As neither chelerythrine nor L-NA demonstrated
complete inhibition of ET
3-stimulated capacitative cal-
cium entry, experiments were performed to investigate
the combined effects of these two inhibitors. Enteric
glia were pretreated with 1 mM L-NA alone, 1 jiM
chelerythrine alone, or with 1 mM L-NA plus 1 jiM
chelerythrine before mobilization of internal calcium
stores by 10 nM ET3. As illustrated in Fig. 8, chel-
erythrine or L-NA alone inhibited ET-stimulated ca-
pacitative calcium entry by ‘-=33%. The combination
of chelerythrine and L-NA caused a synergistic 84
±1% inhibition in parallel experiments.
DISCUSSION
The present studies provide evidence for capacita-
tive calcium entry in cultured enteric glial cells in
which internal calcium stores are mobilized by ET3.
In these cells, capacitative calcium entry is mediated
via non-L-, non-N-, or non-P-type calcium channels.
ET3-stimulated calcium entry was regulated by both
PKC and NO. Inhibitory effects of PKC and NOS were
synergistic, suggesting that PKC- and NO-dependent
pathways are functionally separate.
Several studies have suggested a functional linkage
between increases in [Ca
2~I~and the biological effects
of peptides of th ET family (Supattapone et al., 1989;
Stojilkovic and Catt, 1992; Battistini et al., 1993).
Typically, ET activates a biphasic calcium signal, with
an initial rapid, but transient, rise in [Ca2~ I, followed
by a lower, sustained increment in [Ca2~J~.Previously,
we have reported that ET
3-stimulated calcium signal-
ing in enteric glial cells occurs via ET-B receptor acti-
vation of phospholipase C (Zhang et al., 1997). The
initial rise in [Ca
2~I
1, originating from inositol tris-
phosphate-sensitive intracellular calcium stores, is fol-
lowed by sustained elevation of [Ca
2~
1 due to calcium
entry across the plasma membrane. In these studies,
elevation of enteric glial cell [Ca
2~ 1~ induc d by ET
was reported to last for > 10 mm after agonist expo-
sure. Prolonged elevation of [Ca2~], after exposure to
ET has also been noted in other cell types and may
have a key role in the regulation of DNA synthesis
and cellular proliferation (Supattapone et al., 1989;
Battistini et al., 1993). Prevention of calcium influx
by calcium channel blockers inhibits the mitogenic ef-
fect of ET in smooth muscle cells and astrocytes (Na-
kaki et a!., 1989; Supattapone et al., 1989).
The concept that calcium entry is regulated by the
state of filling of calcium stores was first proposed by
Putney (1990). This capacitative calcium entry has
been observed in many cells and can be activated by
several agonists or pharmacological agents that share
the common property of releasing stored intracellular
calcium. The current study is the first observation of
FIG. 8. Effects of 1
1iM chelerythrine alone, 1 mM L-NA alone, or
a combination of L-NA and chelerythrine on capacitative calcium
entry stimulated by 10 nM ET3 in enteric glia. °p< 0.01, vs. L-
NA alone and chelerythrine alone.
J. Neurochem., Vol. 71, No. 1, 1998
CAPACITATIVE CALCIUM ENTRY IN ENTERIC GLIA 211
capacitative calcium entry inenteric glia. In the current
studies, depletion of intracellular calcium stores by ET
activated calcium entry. Mobilization of intracellular
calcium entry by ET in enteric glia caused barium
influx, confirming that extracellular calcium influx oc-
curring across the cell membrane was the source of the
calcium transient. Increases in [Ca2~ ]~,which occurred
after ET had been removed from the perfusion me-
dium, demonstrated that the continuing presence of
agonist is not required, typical of capacitative calcium
entry in other cell types.
ET-induced capacitative calcium entry in enteric
glia is mediated by Ni 2±- and La3~-inhibitable calcium
channels. The process is not sensitive to L-, N-, or P-
type calcium channel blockers, as capacitative calcium
entry evoked by ET
3 in enteric glia was not affected
by diltiazem, w-conotoxin, or agatoxin. Similar results
have been reported for agonist-stimulated capacitative
calcium entry in other nonexcitable cells (Peterson and
Berridge, 1994; Berridge, 1995; Zhu et al., 1996). The
existence of capacitative calcium entry in enteric glia
with properties similar to those observed in other cell
types suggests the presence of a calcium release-acti-
vated calcium channel. The calcium release-activated
calcium channel has very low conductance and may
be blocked by bivalent and trivalent cations such as
Ni
2~and La3~(Berridge, 1995). Recent studies imply
that the transient receptor potential (trp) gene product
might function as such a capacitative calcium entry
channel (Friel, 1996; Zhu et al., 1996).
The role of PKC in regulation of capacitative cal-
cium entry is uncertain. Recent studies using rat thy-
roid cells, human neutrophils, Xenopus oocytes, pan-
creatic cells, and RBL-2H3 cells have reported that
PKC may either stimulate or inhibit capacitative cal-
cium entry depending on cell type and experimental
conditions (Montero et al., 1993; Tornquist, 1993;
Bode and Goke, 1994; Peterson and Berridge, 1994,
1995; Parekh and Penner, 1995). The current studies
indicate that, in enteric glia, PKC promotes capacita-
live calcium entry. Depletion of cellular PKC activity
by PMA significantly inhibited calcium influx. In a
similar manner, inhibition of PKC activity by chel-
erythrine suppressed calcium entry. These results sug-
gest that PKC may be a factor in the regulation of ET-
stimulated capacitative calcium entry in enteric glia. It
is interesting that inhibition of PKC activity produced
incomplete inhibition of calcium entry. Recent studies
by Shibata et al. (1996) suggest that, in neutrophils,
PKC may regulate the activity of calcium influx factor,
proposed as a soluble mediator for capacitative calcium
entry.
In enteric glia, capacitative calcium entry also ap-
pears to be regulated by NO. Similar to the effects of
PKC inhibitors, inhibitory effects were observed in
experiments using a series of specific NOS antagonists,
L-NA, L-NMMA, L-NIO, and Me-TC. The effects of
L-NA were reversed by SNP, a NO donor. L-NA was
also able to inhibit the barium entry in enteric glia
exposed to ET, indicating that the effects of NO are
exerted at the level of plasma membrane calcium in-
flux.
The role of NO in capacitative calcium entry is un-
certain. Similar to our observations, inhibitory effects
of L-NA on capacitative calcium entry have been re-
ported in carbachol-treated pancreatic cells (Pandol
and Schoeffield-Payne, 1990) and colonic epithelial
cells (Bischof et al., 1995). Other authors have re-
ported no effect of NO on capacitative calcium entry
in rat pancreatic cells (Gilon et al., 1995) and in human
platelets (Okamoto et al., 1995). It is noteworthy that
although PKC or NOS inhibition alone caused only
partial inhibition of ET-evoked calcium entry in enteric
glia, the combination of inhibitors caused near-total
suppression of calcium entry. The synergistic effect of
PKC and NOS inhibitors suggests that PKC and NO
may act on different pathways to regulate capacitative
calcium entry.
In conclusion, the present studies demonstrate that
depletion of internal calcium stores by ET induces Ca-
pacitative calcium entry in enteric glia. Capacitative
calcium entry is mediated by divalent or trivalent cat-
ion-sensitive calcium channels, which are not inhibited
by L-, N-, or P-type calcium channel antagonists. PKC
and NO act synergistically to regulate capacitative cal-
cium entry stimulated by ET in these cells.
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